Understanding how influenza viruses evolve and affect humans and animals
NIAID Centers of Excellence for Influenza Research and Response
This study looks at how flu viruses change and spread among people and animals, and it aims to learn more about how our immune system fights off the flu, so we can make better vaccines to keep everyone healthier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11070185 on NIH RePORTER |
What this research studies
This research investigates the factors that influence the evolution, transmission, and pathogenicity of influenza viruses, focusing on both human and animal populations. It involves cohort studies and sampling to gather data on how these viruses spread and how the immune system responds to infections and vaccinations. By identifying key immunological factors, the research aims to enhance our understanding of protection against influenza and improve vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who have been affected by influenza or are at high risk for infection, such as those with compromised immune systems or chronic health conditions.
Not a fit: Patients who are not at risk for influenza or have no history of respiratory illnesses may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and treatments for influenza, ultimately reducing the impact of the virus on public health.
How similar studies have performed: Previous research has shown success in understanding influenza virus behavior and immune responses, indicating that this approach has the potential for significant advancements.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Tompkins, S. Mark — University of Georgia
- Study coordinator: Tompkins, S. Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.